Discover the pros and cons of AI-augmented risk adjustment and how tech + expertise drive results.

Improving Accuracy & Data Integrity

Defensible, Audit-Ready Records

Automating Clinical Documentation

Precise Coding Across Care Settings

Complete Coding for Ancillary Services

Optimized Codes for Proper Reimbursement

Protecting Revenue Through Coding

Optimizing RAF for Population Health

Analytics-Driven Risk Adjustment

Improving Risk Capture Accuracy

Real-Time Coding for Better Outcomes

Accurate Data From First Touch

Preventing Delays Before Care

Recovering Revenue From Denials

Accelerating Payer Responses

Capturing Charges Without Leakage

Reducing Claim Errors Early

Resolving Credits With Precision

Accurate Payments, Faster Close

Strengthening Payer Appeals

Improving Accuracy Through Expert Audits

Compliance & Risk-Based Training

Risk-Focused Documentation Compliance

Compliance & Risk-Based Training

Risk-Focused Documentation Compliance

How AI Adoption Is Reshaping Healthcare Costs, And Why the BCBS Study May Be Missing the Point

Some conversations are worth having, and this is one of them.

The Blue Cross Blue Shield Association recently released findings linking AI-assisted coding to an estimated $2.3 billion in additional healthcare spending. It’s a number designed to spark reaction, and it has. Across finance, compliance, and policy circles, the narrative is already forming: AI is driving up costs.

But that framing deserves a closer look.

Because the more important story here isn’t just about AI adoption. It’s about how we interpret what AI is revealing.

The Language Around AI Matters More Than We Think

One of the most striking aspects of the BCBS analysis isn’t just the data, it’s the language. The report frequently uses the term “upcoding.” That’s not a casual choice. In healthcare, upcoding carries serious implications. It suggests intentional inflation of diagnoses for financial gain. It suggests misconduct. Yet the conclusions drawn in the study are not based on clinical audits or documentation reviews. They are based on observed billing patterns, specifically, instances where diagnosis complexity appears to rise faster than treatment intensity. That’s a meaningful signal. But it’s not definitive proof of inappropriate coding. And treating it as such risks oversimplifying a much more nuanced shift happening across healthcare.

What the Data Actually Shows?

At the center of the study is a pattern: diagnoses are becoming more detailed, and in some cases, more complex. A commonly cited example is maternity care, where hospitals reported an increase in diagnoses like acute posthemorrhagic anemia without a corresponding rise in transfusions.

On the surface, that raises questions.

But clinical reality is rarely that linear.

Under ICD-10-CM guidelines, a diagnosis doesn’t depend on a single intervention. It can be supported by evaluation, monitoring, diagnostic work, or increased care intensity. A transfusion is one possible response, not the defining threshold for whether a condition exists.

So when documentation becomes more precise, reimbursement models respond accordingly. That doesn’t necessarily mean the system is being manipulated. It may mean the system is finally capturing what was always there.

AI isn’t Just Changing Workflows; it’s Changing Visibility

What makes this moment different from previous waves of healthcare technology is that AI is now embedded on both sides of the revenue cycle. Providers are using AI to document care more thoroughly, often in real time. Ambient listening tools capture clinical conversations, while coding systems analyze notes and suggest diagnoses that may have previously gone unreported. At the same time, payors are deploying their own algorithms to review those claims, flagging patterns, comparing treatment pathways, and identifying anomalies at scale. For the first time, the revenue cycle is being shaped by automation interacting with automation. That dynamic creates friction, but it also creates visibility. And with greater visibility comes greater scrutiny.

The Question We Should Be Asking

The conversation today is focused on why coding intensity is increasing.

But that may not be the most important question.

A more meaningful one is:

Why was clinical complexity so consistently underrepresented before?

For years, healthcare organizations operated within constraints that limited documentation accuracy. Time pressures, manual workflows, and fragmented systems often meant that only the most obvious conditions were captured. Subtle comorbidities, secondary diagnoses, and nuanced clinical indicators were frequently missed.

AI hasn’t created complexity.

It has exposed it.

And that exposure is now colliding with reimbursement models that were built around less detailed inputs.

Where AI Alone Falls Short?

None of this suggests that AI should be accepted without scrutiny. It shouldn’t. As adoption accelerates, a new kind of operational gap is emerging, one between what AI can generate and what organizations are prepared to validate. When AI-suggested diagnoses move into claims without proper clinical grounding, risk increases. Not necessarily because the technology is flawed, but because the surrounding processes aren’t keeping pace. This is where expertise becomes critical. Clinical Documentation Integrity (CDI) acts as the checkpoint between documentation and reimbursement, ensuring that every coded diagnosis reflects actual clinical decision-making. Coding audits provide another layer of protection, identifying patterns that could trigger payor scrutiny. And strong revenue cycle governance ensures that documentation, coding, and financial outcomes remain aligned. In other words, AI doesn’t eliminate the need for expertise. It amplifies it.

Reframing the Narrative Around Cost

The BCBS study frames its findings in terms of increased spending. That’s understandable, cost is a central concern across the healthcare system. But cost alone doesn’t tell the full story. If more accurate documentation leads to higher reimbursement, the question isn’t simply whether spending increased. It’s whether reimbursement is now more closely aligned with actual patient complexity. That’s a very different conversation. And it’s one that requires moving beyond surface-level interpretations of the data.

The Bottom Line

AI is no longer experimental in healthcare. It’s operational. It’s embedded. And it’s influencing how care is documented, coded, and reimbursed at scale.

What happens next won’t be defined by how quickly organizations adopt AI, but by how effectively they interpret and govern its outputs.

Because the real risk isn’t that AI is changing the system.

It’s that we might misunderstand what those changes actually mean.

And in a revenue cycle increasingly shaped by automation on both sides, that misunderstanding can be just as costly as any coding error.

FAQs

1. Is AI actually increasing healthcare costs?

Not necessarily. AI is often improving the accuracy and completeness of clinical documentation, which can lead to higher reported costs. However, this may reflect previously underreported patient complexity rather than true cost inflation.

2. Does more detailed coding always mean higher reimbursement?

Often, yes. Many reimbursement models are tied to the documented severity and complexity of a patient’s condition. When AI improves documentation accuracy, reimbursement may increase accordingly.

3. How does AI impact clinical documentation?

AI tools such as ambient listening and automated coding assistants help capture clinical interactions in real time and suggest relevant diagnoses. This reduces missed information and enhances documentation completeness.

4. Does increased coding intensity always indicate fraud or misuse?

No. Increased coding intensity can result from better documentation rather than intentional inflation. It’s important to distinguish between improved accuracy and inappropriate coding practices.

5. What role does Clinical Documentation Integrity (CDI) play in an AI-driven environment?

CDI ensures that all documented and coded diagnoses accurately reflect clinical care. It acts as a safeguard, validating AI-generated insights before they impact billing and reimbursement.

Author Bio:

Kanar Kokoy

CEO - Chirok Health

Healthcare CEO & CDI/RCM innovator. I help orgs boost accuracy, integrity & revenue via truthful clinical docs. Led transformations in CDI, coding, AI solutions, audits & VBC for health systems, ACOs & more. Let’s connect to modernize workflows.

Table of Contents

Please enter your email address to download the White Paper.